Emirates Drug Foundation and Arcelor Sign MoU to Boost Pharmaceutical Manufacturing
📋 Key Takeaway: The Emirates Drug Foundation has signed a memorandum of understanding with Arcelor to enhance pharmaceutical manufacturing capabilities in the UAE during the ‘Made in the UAE’ exhibition.
Collaboration to Enhance Local Pharmaceutical Manufacturing
The Emirates Drug Foundation and Arcelor, a global leader in life sciences, have formalized a memorandum of understanding (MoU) aimed at bolstering pharmaceutical manufacturing in the United Arab Emirates. This agreement was signed on the sidelines of the ‘Made in the UAE’ exhibition, taking place from May 4 to 7 at the Abu Dhabi National Exhibition Centre (ADNEC). The MoU emphasizes a collaborative framework that focuses on enhancing local manufacturing capabilities, developing national talent, and supporting research and innovation.
Under the terms of the agreement, both parties will implement training programs and workshops designed to localize the medical products sector and develop the skills of Emirati professionals. This initiative is expected to play a significant role in the UAE’s efforts to nationalize the workforce in advanced pharmaceutical manufacturing environments.
The partnership also aims to expand the production capacity of pharmaceuticals within the country, attract investments to the sector, and strengthen the strategic stockpile of medications to ensure their availability and continuity of supply. This is crucial for enhancing the national readiness to meet vital health needs.
Strategic Initiatives and Future Prospects
In addition to supporting various initiatives led by the Emirates Drug Foundation, Arcelor will contribute to programs aimed at strengthening the pharmaceutical manufacturing sector in the UAE. The company plans to provide training programs at its manufacturing facilities, enhancing the readiness of national talent for the job market and opening future employment opportunities.
Isabel Afonso, CEO of Arcelor, highlighted that the development of the pharmaceutical sector requires ongoing coordination between government entities and the industrial sector. She noted that this partnership translates the vision into actionable steps by supporting local manufacturing, training skilled professionals, and ensuring sustainable and reliable access to essential treatments.
The ‘Made in the UAE’ exhibition, now in its fifth year, serves as a key platform for advancing the country’s industrial agenda. It brings together government entities, industry leaders, and investors to foster partnerships and stimulate investment.
About Arcelor Life Sciences
Arcelor is a global leader in life sciences, engaged in the development, manufacturing, and marketing of a wide range of innovative and effective medications across major international markets. With its main operations based in Abu Dhabi, the company benefits from a strong presence in over 90 markets worldwide. Arcelor’s advanced operational infrastructure includes manufacturing and packaging facilities in eight countries, enabling it to offer a diverse pharmaceutical portfolio of over 2,000 products across multiple therapeutic areas.
Through its mission, Arcelor supports Abu Dhabi’s vision of establishing the emirate as a global hub for innovative and sustainable healthcare, empowering individuals to lead longer and healthier lives. Arcelor was established by ADQ, an investment holding company based in Abu Dhabi.
Frequently Asked Questions
What is the purpose of the MoU between Emirates Drug Foundation and Arcelor?
The MoU aims to enhance pharmaceutical manufacturing capabilities in the UAE, focusing on local production and workforce development.
When and where was the MoU signed?
The MoU was signed during the ‘Made in the UAE’ exhibition at ADNEC from May 4 to 7.
What initiatives will Arcelor support under the agreement?
Arcelor will support training programs and initiatives aimed at strengthening the local pharmaceutical sector.
How does this partnership impact the UAE’s healthcare sector?
The partnership is expected to enhance the national readiness to meet health needs by expanding production capacity and ensuring a reliable supply of medications.
What is Arcelor’s role in the pharmaceutical market?
Arcelor is a global leader in life sciences, developing and marketing a wide range of innovative medications.
